Obermeyer Wood Investment Counsel Lllp Reduces Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Obermeyer Wood Investment Counsel Lllp lessened its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 12.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 12,066 shares of the company’s stock after selling 1,726 shares during the quarter. Obermeyer Wood Investment […]

Related Keywords

Canada ,China ,Hong Kong ,Williamd Waddill , ,Ameritas Investment Partners Inc ,Jpmorgan Chase Co ,Protagonist Therapeutics Inc ,China Universal Asset Management Co ,Securities Exchange Commission ,Hong Kong Ltd ,Nasdaq ,Royal Bank ,Tower Research Capital ,Obermeyer Wood Investment Counsel Lllp ,Protagonist Therapeutics ,Free Report ,Wood Investment Counsel Lllp ,Universal Asset Management ,Research Capital ,Investment Partners ,Kong Ltd ,Get Free Report ,Director William ,Exchange Commission ,Protagonist Therapeutics Daily ,Nasdaq Ptgx ,Ptgx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,